Search results
New Study Suggests Cancer Drug Could Be Used to Ta | Newswise
Newswise· 1 day agoIn studies with genetically engineered mice, Johns Hopkins Medicine researchers say they have identified a potentially new biological target involving Aplp1 ...
Engineered purple tomato company Norfolk Healthy Produce sees sales surge - Sacramento Business...
The Business Journals· 6 days agoThe first genetically engineered produce developed to appeal to consumers for its nutritional value...
Can engineered plants help make baby formula as nutritious as breast milk? - Berkeley News
UC Berkeley NewsCenter· 5 days agoNew research led by scientists at the University of California, Berkeley, and the University of...
Could CRISPR Genome Editing Technology Impact Your Business?
Forbes· 1 day agoOne of the SciTech trends I’m currently paying attention to is how scientists are developing CRISPR...
Common low-calorie sweetener linked to heart attack and stroke, study finds
CNN via Yahoo News· 4 days agoA common low-calorie sweetener called xylitol, found in gum, candy, toothpaste and more, may cause...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
United Press International via Yahoo News· 5 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
The Day the Meat Wars Came for Joey Chestnut
The New Republic via Yahoo Sports· 6 days agoImpossible Foods’ products are plant-based. Its trademark ingredient is a genetically engineered protein called heme, which adds a meaty flavor to...
Science celebrates World Biotechnology Day
Hardwood Paroxysm· 2 days agoThis day is dedicated to raising awareness about the importance of biotechnology and its applications to improve the quality of human life and the environment. This international day is celebrated ...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 6 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...
OS Therapies Inc. Prices IPO at $4.00 Per Share (OSTX)
ETF DAILY NEWS· 2 days agoOS Therapies Inc. (OSTX) plans to raise $8 million in an initial public offering on Thursday, June 20th, IPO Scoop reports. The company will be issuing 2,000,000 shares at a price of $4.00 per ...
